(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VANDRIA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VANDRIA

ST13

US500000090905974

Class

5, 42

Filing

90905974

Registration

8026795

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

12/20/2025

Trademark type

Word

Nice classes

5, 42

Filing date

08/27/2021

Registration date

11/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2025

Last transaction

12/20/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

LAUSANNE, CH

Examiner

CORNWELL,ANDREA B

Law office

M60

Current location

PETITIONS OFFICE

Holders and representatives

Holders

VANDRIA SA
Amazentis SA

Representatives

Joshua S. Jarvis, Esq. FOLEY HOAG LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals for the treatment of mitochondrial diseasesdisordersconditionscardiovascular diseasesdisordersconditionsmusculoskeletal diseasesdisordersconditionsmuscular diseasesdisordersconditionsbone diseasesdisordersconditionsneurological and neurodegenerative diseasesdisordersconditionsmetabolic diseasesdisordersconditionsrenal diseasesdisordersconditionsophthalmological diseasesdisordersconditionsoncological diseasesdisordersconditionsimmune system and autoimmune diseasesdisordersconditionsendocrine system diseasesdisordersconditionspulmonary and respiratory diseasesdisordersconditionshepatic diseasesdisordersconditionsgastrointestinal diseasesdisordersconditionsdiseasesdisordersconditions related to aging

Class 42

Research and development of pharmaceuticals in the fields of mitochondrial diseasesdisordersconditionscardiovascular diseasesdisordersconditionsmusculoskeletal diseasesdisordersconditionsmuscular diseasesdisordersconditionsbone diseasesdisordersconditionsneurological and neurodegenerative diseasesdisordersconditionsmetabolic diseasesdisordersconditionsrenal diseasesdisordersconditionsophthalmological diseasesdisordersconditionsoncological diseasesdisordersconditionsimmune system and autoimmune diseasesdisordersconditionsendocrine system diseasesdisordersconditionspulmonary and respiratory diseasesdisordersconditionshepatic diseasesdisordersconditionsgastrointestinal diseasesdisordersconditionsdiseasesdisordersconditions related to aging

Publications

History of USPTO decisions and trademark events.

44 publications found

PPAD

POST PUBLICATION AMENDMENT REVIEWED – NO ACTION TAKEN

12/19/2025

APET

ASSIGNED TO PETITION STAFF

12/11/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/18/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/24/2025

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

10/23/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/23/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/26/2025

EX5G

SOU EXTENSION 5 GRANTED

08/26/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/26/2025

EEXT

SOU TEAS EXTENSION RECEIVED

04/23/2025

EXT5

SOU EXTENSION 5 FILED

04/22/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/25/2024

EX4G

SOU EXTENSION 4 GRANTED

10/25/2024

EXT4

SOU EXTENSION 4 FILED

10/25/2024

EEXT

SOU TEAS EXTENSION RECEIVED

10/25/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/09/2024

EX3G

SOU EXTENSION 3 GRANTED

04/08/2024

EXT3

SOU EXTENSION 3 FILED

04/08/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/08/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/20/2023

EX2G

SOU EXTENSION 2 GRANTED

09/18/2023

EXT2

SOU EXTENSION 2 FILED

09/18/2023

EEXT

SOU TEAS EXTENSION RECEIVED

09/18/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/25/2023

EX1G

SOU EXTENSION 1 GRANTED

03/23/2023

EXT1

SOU EXTENSION 1 FILED

03/23/2023

EEXT

SOU TEAS EXTENSION RECEIVED

03/23/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/13/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/18/2022

PUBO

PUBLISHED FOR OPPOSITION

10/18/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/28/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/09/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/02/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/02/2022

ALIE

ASSIGNED TO LIE

09/01/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

08/03/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

06/06/2022

GNSL

LETTER OF SUSPENSION E-MAILED

06/06/2022

CNSL

SUSPENSION LETTER WRITTEN

06/06/2022

DOCK

ASSIGNED TO EXAMINER

06/02/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

01/26/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/29/2021

NWAP

NEW APPLICATION ENTERED

08/31/2021

Continuous trademark protection

Get notified about every new filing that threatens VANDRIA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.